Khrom Capital Management LLC Invests $5 Million in Sotera Health (NASDAQ:SHC)

Khrom Capital Management LLC purchased a new position in shares of Sotera Health (NASDAQ:SHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 365,386 shares of the company's stock, valued at approximately $4,998,000. Sotera Health accounts for approximately 0.6% of Khrom Capital Management LLC's investment portfolio, making the stock its 18th biggest holding. Khrom Capital Management LLC owned approximately 0.13% of Sotera Health at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its position in Sotera Health by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company's stock valued at $204,154,000 after acquiring an additional 173,341 shares during the period. Dimensional Fund Advisors LP increased its holdings in Sotera Health by 27.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after buying an additional 673,979 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Sotera Health by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 2,780,445 shares of the company's stock valued at $38,048,000 after acquiring an additional 25,054 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Sotera Health by 45.1% during the 4th quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company's stock valued at $22,308,000 after acquiring an additional 507,147 shares in the last quarter. Finally, Norges Bank acquired a new position in Sotera Health in the fourth quarter worth $12,764,000. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Trading Down 2.5 %

Shares of NASDAQ:SHC traded down $0.28 during midday trading on Friday, reaching $11.02. The company had a trading volume of 13,928 shares, compared to its average volume of 1,198,557. The company has a fifty day simple moving average of $11.61 and a two-hundred day simple moving average of $13.20. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm has a market cap of $3.13 billion, a price-to-earnings ratio of 44.11 and a beta of 1.88. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on SHC shares. Piper Sandler lowered their price objective on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday. Barclays decreased their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $15.20.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.